BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 3, 2010
View Archived Issues
Product Candidate Arikace Key to Insmed-Transave Merger
Read More
PhaseBio Adds $15M to Series B, Heads for GLP-1
Read More
U.S. Patent Disclosures
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Merck Buying Insulin Maker SmartCells in $500M Deal
Looking to beef up its diabetes pipeline, pharma giant Merck & Co. Inc. is acquiring insulin maker SmartCells Inc. in a deal potentially worth $500 million, including an undisclosed up-front payment.
Read More
SGEN, Onyx, Multiple Myeloma Data Top ASH Must-See Lists
Read More
